?
Ji Henry
President, CEO and Chairman of the Board of Directors
Sorrento Therapeutics, Inc.
US, San Diego [HQ]
CIK
1470981
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
2,121,362
Price per Share :
$0.00
Equivalence :
$0.0
Transaction History
-
P2,121,362 Shares After TransactionValue : $4,476,073.82$70,332.63Transaction Date : 08/26/22
-
Footnotes
-
-
Footnotes:No footnote found.
-
P4,765,805 Shares After TransactionValue : $9,626,926.10$179,553.76Transaction Date : 09/07/22
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.02, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
-
A6,265,805 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/15/22
-
Footnotes
-
-
Footnotes:#1 The grant to the Reporting Person of a restricted stock unit award for 1,500,000 shares of the Issuer's common stock (the "RSU Award") was approved by the compensation committee of the board of directors of the Issuer on September 1, 2022 and was granted to the Reporting Person on September 2, 2022. The RSU Award was conditioned upon and subject to the Issuer's stockholders approving an amendment to the Issuer's 2019 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder (the "Plan Amendment"). The Issuer's stockholders approved the Plan Amendment on December 15, 2022.#2 The reported securities are shares subject to the RSU Award. 1/4th of the shares subject to the RSU Award shall vest on September 2, 2023 and 1/4th of the shares subject to the RSU Award shall vest on each anniversary thereafter.
-
X20,000 Shares After TransactionValue : $16,000.00$15,600.00Transaction Date : 03/17/23
-
Footnotes
-
-
Footnotes:#1 On December 30, 2022, the Issuer's Board of Directors declared a stock dividend (the "Dividend") to all holders of record of its common stock as of the close of business on January 9, 2023, of 0.1410127 of a share of common stock, par value $0.0001 per share, of Scilex Holding Company ("Scilex Common Stock") for each one share of common stock, par value $0.0001 per share, of the Issuer ("Sorrento Common Stock"). The Put Option written by the Reporting Person on August 26, 2022 (the "Put Option") was previously reported at an exercise price of $5.50 per share of Sorrento Common Stock, which was adjusted as a result of the Dividend to relate to an aggregate of 19,500 shares of Sorrento Common Stock and 2,730 shares of Scilex Common Stock and to reflect a corresponding change to the exercise price of the Put Option to $0.80268 per share of Sorrento Common Stock and $8.6002 per share of Scilex Common Stock. The Put Option settled on March 17, 2023 and resulted in the Reporting Person#2 (Continued Footnote 1) acquiring 19,500 shares of Sorrento Common Stock at a price of $0.80268 per share of Sorrento Common Stock, in addition to 2,730 shares of Scilex Common Stock at a price of $8.6002 per share of Scilex Common Stock.
-
M2,055,807 Shares After TransactionValue : $8,223,228.00$40,000.00Transaction Date : 09/29/21
-
Footnotes
-
-
Footnotes:No footnote found.